Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
0 hedge funds and large institutions have $0 invested in Celgene Corporation Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 24 closing their positions.
100% less funds holding
Funds holding: 24 → 0 (-24)
100% less capital invested
Capital invested by funds: $218K → $0 (-$218K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 24
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
-$70K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$42K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$30K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$15K |
| 5 |
DAM
Deltec Asset Management
New York
|
-$12K |
CELGZ Hedge Fund Activity: Q4 2019 in Review
0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q4 2019, worth a combined $0 — down 100% from $218K a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of CELGZ and 0 opened new positions — a net loss of 24 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Davenport & Co, exiting entirely with an estimated $70K sold.
- 0 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q4 2019, down from 24 in Q3 2019.
- Funds reported $0 of Celgene Corporation Contingent Value Rights stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new Celgene Corporation Contingent Value Rights positions in Q4 2019 and 24 closed out, a net change of -24 holders.
- The largest Celgene Corporation Contingent Value Rights seller in Q4 2019 was Davenport & Co, an estimated $70K sold.
Based on aggregated 13F filings for Q4 2019.